Semaglutide Produced in:
Semaglutide is an analog of glucagon-like peptide-1 (GLP-1). It is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. And also, to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.
Please submit a detailed description of your request. We will provide you with professional services to meet your research requests. You can also send emails directly to email@example.com for inquiries.